| Symbol |
Name |
|
A4GALT
|
alpha 1,4-galactosyltransferase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABHD4
|
abhydrolase domain containing 4
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACAD10
|
acyl-CoA dehydrogenase family, member 10
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACSM3
|
acyl-CoA synthetase medium-chain family member 3
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACVR1C
|
activin A receptor, type IC
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADCY8
|
adenylate cyclase 8 (brain)
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADGRA2
|
adhesion G protein-coupled receptor A2
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKAP5
|
A kinase (PRKA) anchor protein 5
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
ALB
|
albumin
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALPP
|
alkaline phosphatase, placental
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL6
|
angiopoietin-like 6
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANO2
|
anoctamin 2, calcium activated chloride channel
|
|
ANO6
|
anoctamin 6
|
|
ANXA10
|
annexin A10
|
|
ANXA2
|
annexin A2
|
|
ANXA6
|
annexin A6
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APTX
|
aprataxin
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AQP7
|
aquaporin 7
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5
|
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa
|
|
ARRB2
|
arrestin, beta 2
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASIP
|
agouti signaling protein
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATF4
|
activating transcription factor 4
|
|
ATG5
|
autophagy related 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATMIN
|
ATM interactor
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP5J
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BBS12
|
Bardet-Biedl syndrome 12
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLOC1S4
|
biogenesis of lysosomal organelles complex-1, subunit 4, cappuccino
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTNL2
|
butyrophilin-like 2
|
|
C3
|
complement component 3
|
|
C5AR2
|
complement component 5a receptor 2
|
|
CA6
|
carbonic anhydrase VI
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CACNA2D3
|
calcium channel, voltage-dependent, alpha 2/delta subunit 3
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN10
|
calpain 10
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CATSPER1
|
cation channel, sperm associated 1
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNG1
|
cyclin G1
|
|
CCNT1
|
cyclin T1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD3EAP
|
CD3e molecule, epsilon associated protein
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD63
|
CD63 molecule
|
|
CD70
|
CD70 molecule
|
|
CD81
|
CD81 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD9
|
CD9 molecule
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC73
|
cell division cycle 73
|
|
CDH13
|
cadherin 13
|
|
CDIP1
|
cell death-inducing p53 target 1
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CENPW
|
centromere protein W
|
|
CES2
|
carboxylesterase 2
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGA
|
chromogranin A
|
|
CHRNA2
|
cholinergic receptor, nicotinic, alpha 2 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLDN1
|
claudin 1
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLIP1
|
CAP-GLY domain containing linker protein 1
|
|
CLOCK
|
clock circadian regulator
|
|
CLPTM1L
|
CLPTM1-like
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CRBN
|
cereblon
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTF1
|
cardiotrophin 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTPS2
|
CTP synthase 2
|
|
CTSH
|
cathepsin H
|
|
CUL5
|
cullin 5
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYC1
|
cytochrome c-1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
DCK
|
deoxycytidine kinase
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEL22Q11.2
|
Chromosome 22q11.2 deletion syndrome, distal
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLG2
|
discs, large homolog 2 (Drosophila)
|
|
DLG3
|
discs, large homolog 3 (Drosophila)
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
DNAJC15
|
DnaJ (Hsp40) homolog, subfamily C, member 15
|
|
DNASE1
|
deoxyribonuclease I
|
|
DND1
|
DND microRNA-mediated repression inhibitor 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSP
|
desmoplakin
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EDN1
|
endothelin 1
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF3H
|
eukaryotic translation initiation factor 3, subunit H
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4
|
|
ELF5
|
E74-like factor 5 (ets domain transcription factor)
|
|
ELN
|
elastin
|
|
ELOVL6
|
ELOVL fatty acid elongase 6
|
|
ENDOG
|
endonuclease G
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENTPD4
|
ectonucleoside triphosphate diphosphohydrolase 4
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERCC6L
|
excision repair cross-complementation group 6-like
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV4
|
ets variant 4
|
|
ETV6
|
ets variant 6
|
|
EXO1
|
exonuclease 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAIM2
|
Fas apoptotic inhibitory molecule 2
|
|
FAM168A
|
family with sequence similarity 168, member A
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBN1
|
fibrillin 1
|
|
FBXO5
|
F-box protein 5
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FGF14
|
fibroblast growth factor 14
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHL1
|
four and a half LIM domains 1
|
|
FKBP6
|
FK506 binding protein 6, 36kDa
|
|
FKBPL
|
FK506 binding protein like
|
|
FLG
|
filaggrin
|
|
FLNA
|
filamin A, alpha
|
|
FLOT2
|
flotillin 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOXA2
|
forkhead box A2
|
|
FOXC1
|
forkhead box C1
|
|
FOXC2
|
forkhead box C2
|
|
FOXD2
|
forkhead box D2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FXN
|
frataxin
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD9
|
frizzled class receptor 9
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GALE
|
UDP-galactose-4-epimerase
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS6
|
growth arrest-specific 6
|
|
GAST
|
gastrin
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GBF1
|
golgi brefeldin A resistant guanine nucleotide exchange factor 1
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJA3
|
gap junction protein, alpha 3, 46kDa
|
|
GJA8
|
gap junction protein, alpha 8, 50kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRA2
|
glycine receptor, alpha 2
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GOLM1
|
golgi membrane protein 1
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPC3
|
glypican 3
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX3
|
glutathione peroxidase 3
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2C
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2C
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRN
|
granulin
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTA4
|
glutathione S-transferase alpha 4
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
GUCY2F
|
guanylate cyclase 2F, retinal
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC5
|
histone deacetylase 5
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC9
|
histone deacetylase 9
|
|
HECA
|
headcase homolog (Drosophila)
|
|
HELQ
|
helicase, POLQ-like
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HFE
|
hemochromatosis
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HJURP
|
Holliday junction recognition protein
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HOXA6
|
homeobox A6
|
|
HOXD11
|
homeobox D11
|
|
HOXD12
|
homeobox D12
|
|
HP
|
haptoglobin
|
|
HPS6
|
Hermansky-Pudlak syndrome 6
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPH1
|
heat shock 105kDa/110kDa protein 1
|
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGK
|
immunoglobulin kappa locus
|
|
IGL
|
immunoglobulin lambda locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12A
|
interleukin 12A
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL20RA
|
interleukin 20 receptor, alpha
|
|
IL26
|
interleukin 26
|
|
IL33
|
interleukin 33
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IMP3
|
IMP3, U3 small nucleolar ribonucleoprotein
|
|
INHA
|
inhibin, alpha
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IP6K2
|
inositol hexakisphosphate kinase 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
ITPRIP
|
inositol 1,4,5-trisphosphate receptor interacting protein
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JSRP1
|
junctional sarcoplasmic reticulum protein 1
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNA4
|
potassium channel, voltage gated shaker related subfamily A, member 4
|
|
KCNB1
|
potassium channel, voltage gated Shab related subfamily B, member 1
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNK5
|
potassium channel, two pore domain subfamily K, member 5
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNMB4
|
potassium channel subfamily M regulatory beta subunit 4
|
|
KCNN2
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KCNV2
|
potassium channel, voltage gated modifier subfamily V, member 2
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA1524
|
KIAA1524
|
|
KIF20A
|
kinesin family member 20A
|
|
KIN
|
Kin17 DNA and RNA binding protein
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF13
|
Kruppel-like factor 13
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLF7
|
Kruppel-like factor 7 (ubiquitous)
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT6B
|
keratin 6B, type II
|
|
KSR1
|
kinase suppressor of ras 1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LANCL2
|
LanC lantibiotic synthetase component C-like 2 (bacterial)
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LEPROT
|
leptin receptor overlapping transcript
|
|
LEPROTL1
|
leptin receptor overlapping transcript-like 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS4
|
lectin, galactoside-binding, soluble, 4
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIPC
|
lipase, hepatic
|
|
LIPG
|
lipase, endothelial
|
|
LMNA
|
lamin A/C
|
|
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LOX
|
lysyl oxidase
|
|
LPIN1
|
lipin 1
|
|
LPL
|
lipoprotein lipase
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTF
|
lactotransferrin
|
|
LY75
|
lymphocyte antigen 75
|
|
LY96
|
lymphocyte antigen 96
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYPLAL1
|
lysophospholipase-like 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L2
|
MAD2 mitotic arrest deficient-like 2 (yeast)
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED25
|
mediator complex subunit 25
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR100
|
microRNA 100
|
|
MIR103A1
|
microRNA 103a-1
|
|
MIR122
|
microRNA 122
|
|
MIR125A
|
microRNA 125a
|
|
MIR1287
|
microRNA 1287
|
|
MIR138-1
|
microRNA 138-1
|
|
MIR141
|
microRNA 141
|
|
MIR143
|
microRNA 143
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR187
|
microRNA 187
|
|
MIR195
|
microRNA 195
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR214
|
microRNA 214
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR224
|
microRNA 224
|
|
MIR27A
|
microRNA 27a
|
|
MIR302A
|
microRNA 302a
|
|
MIR30A
|
microRNA 30a
|
|
MIR31
|
microRNA 31
|
|
MIR34A
|
microRNA 34a
|
|
MIR367
|
microRNA 367
|
|
MIR381
|
microRNA 381
|
|
MIR497
|
microRNA 497
|
|
MIR657
|
microRNA 657
|
|
MIR98
|
microRNA 98
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP19
|
matrix metallopeptidase 19
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
MORF4L1
|
mortality factor 4 like 1
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSLN
|
mesothelin
|
|
MSN
|
moesin
|
|
MSX2
|
msh homeobox 2
|
|
MT1G
|
metallothionein 1G
|
|
MTCH2
|
mitochondrial carrier 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTMR9
|
myotubularin related protein 9
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC3A
|
mucin 3A, cell surface associated
|
|
MVK
|
mevalonate kinase
|
|
MX2
|
MX dynamin-like GTPase 2
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCAM2
|
neural cell adhesion molecule 2
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NDUFB6
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEGR1
|
neuronal growth regulator 1
|
|
NEIL2
|
nei endonuclease VIII-like 2 (E. coli)
|
|
NEIL3
|
nei endonuclease VIII-like 3 (E. coli)
|
|
NES
|
nestin
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-2
|
NK2 homeobox 2
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPRL2
|
nitrogen permease regulator-like 2 (S. cerevisiae)
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRG3
|
neuregulin 3
|
|
NT5C2
|
5'-nucleotidase, cytosolic II
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCB2
|
nucleobindin 2
|
|
NUMB
|
numb homolog (Drosophila)
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLA1
|
Obg-like ATPase 1
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPN4
|
opsin 4
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OSMR
|
oncostatin M receptor
|
|
OTX2
|
orthodenticle homeobox 2
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX8
|
paired box 8
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PEX26
|
peroxisomal biogenesis factor 26
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PHLPP2
|
PH domain and leucine rich repeat protein phosphatase 2
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PID1
|
phosphotyrosine interaction domain containing 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP
|
prolactin-induced protein
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLK1
|
polo-like kinase 1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLQ
|
polymerase (DNA directed), theta
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
PON3
|
paraoxonase 3
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1K
|
protein phosphatase, Mg2+/Mn2+ dependent, 1K
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R3C
|
protein phosphatase 2, regulatory subunit B'', gamma
|
|
PPP6C
|
protein phosphatase 6, catalytic subunit
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDX4
|
peroxiredoxin 4
|
|
PREX2
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRLR
|
prolactin receptor
|
|
PRPF4B
|
pre-mRNA processing factor 4B
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PSEN1
|
presenilin 1
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTOV1
|
prostate tumor overexpressed 1
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRF
|
protein tyrosine phosphatase, receptor type, F
|
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
|
PTPRVP
|
protein tyrosine phosphatase, receptor type, V, pseudogene
|
|
PVALB
|
parvalbumin
|
|
PVR
|
poliovirus receptor
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYY
|
peptide YY
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51B
|
RAD51 paralog B
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALBP1
|
ralA binding protein 1
|
|
RANBP1
|
RAN binding protein 1
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RECQL4
|
RecQ protein-like 4
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RHOJ
|
ras homolog family member J
|
|
RLN1
|
relaxin 1
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF2
|
ring finger protein 2
|
|
RORC
|
RAR-related orphan receptor C
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPL19
|
ribosomal protein L19
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RRAD
|
Ras-related associated with diabetes
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RTN1
|
reticulon 1
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR3
|
ryanodine receptor 3
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
S1PR4
|
sphingosine-1-phosphate receptor 4
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SBF1
|
SET binding factor 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SECISBP2
|
SECIS binding protein 2
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFN
|
stratifin
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT4
|
sirtuin 4
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC25A6
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC31A2
|
solute carrier family 31 (copper transporter), member 2
|
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMG1
|
SMG1 phosphatidylinositol 3-kinase-related kinase
|
|
SMTN
|
smoothelin
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNX2
|
sorting nexin 2
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A3
|
steroid 5 alpha-reductase 3
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SSTR1
|
somatostatin receptor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STEAP4
|
STEAP family member 4
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SULF2
|
sulfatase 2
|
|
SYK
|
spleen tyrosine kinase
|
|
SYT2
|
synaptotagmin II
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACC3
|
transforming, acidic coiled-coil containing protein 3
|
|
TAS1R1
|
taste receptor, type 1, member 1
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TAS2R16
|
taste receptor, type 2, member 16
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFF1
|
trefoil factor 1
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TGM2
|
transglutaminase 2
|
|
TGM6
|
transglutaminase 6
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIGAR
|
TP53 induced glycolysis regulatory phosphatase
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TMX1
|
thioredoxin-related transmembrane protein 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TNS4
|
tensin 4
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPCN2
|
two pore segment channel 2
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRH
|
thyrotropin-releasing hormone
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM16
|
tripartite motif containing 16
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRO
|
trophinin
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTR
|
transthyretin
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE2T
|
ubiquitin-conjugating enzyme E2T
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
UMPS
|
uridine monophosphate synthetase
|
|
UNG
|
uracil-DNA glycosylase
|
|
UPK2
|
uroplakin 2
|
|
USF1
|
upstream transcription factor 1
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
UTS2
|
urotensin 2
|
|
UTS2R
|
urotensin 2 receptor
|
|
UVRAG
|
UV radiation resistance associated
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS33A
|
vacuolar protein sorting 33 homolog A (S. cerevisiae)
|
|
VSNL1
|
visinin-like 1
|
|
VWF
|
von Willebrand factor
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WISP3
|
WNT1 inducible signaling pathway protein 3
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WSB1
|
WD repeat and SOCS box containing 1
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZNF195
|
zinc finger protein 195
|
|
ZNF350
|
zinc finger protein 350
|
|
ZNF516
|
zinc finger protein 516
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
